Literature DB >> 18709468

The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Bryan K Yamamoto1, Jamie Raudensky.   

Abstract

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709468      PMCID: PMC3955110          DOI: 10.1007/s11481-008-9121-7

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  165 in total

1.  Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.

Authors:  Y Gasche; J C Copin; T Sugawara; M Fujimura; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

2.  Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6.

Authors:  B Ladenheim; I N Krasnova; X Deng; J M Oyler; A Polettini; T H Moran; M A Huestis; J L Cadet
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus.

Authors:  Arek Szklarczyk; Joanna Lapinska; Marcin Rylski; Ronald D G McKay; Leszek Kaczmarek
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function.

Authors:  D W Moss; T E Bates
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

5.  Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.

Authors:  M R Gluck; L Y Moy; E Jayatilleke; K A Hogan; L Manzino; P K Sonsalla
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

6.  The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge.

Authors:  V Ben-Shaul; L Lomnitski; A Nyska; Y Zurovsky; M Bergman; S Grossman
Journal:  Toxicol Lett       Date:  2001-08-06       Impact factor: 4.372

Review 7.  Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Authors:  A E Fleckenstein; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

8.  Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis.

Authors:  C Rocher; A M Gardier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-04       Impact factor: 3.000

Review 9.  Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death.

Authors:  R Sattler; M Tymianski
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

Review 10.  Metalloproteinases in biology and pathology of the nervous system.

Authors:  V W Yong; C Power; P Forsyth; D R Edwards
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

View more
  71 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

Review 2.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 3.  Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.

Authors:  Josh Lister; José N Nobrega; Paul J Fletcher; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

4.  Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Mohammad Abdollahi; Mansour Heidari; Zahra Madjd
Journal:  Neurotox Res       Date:  2017-01-11       Impact factor: 3.911

5.  Enhanced brain distribution of modified aspartoacylase.

Authors:  Nitesh K Poddar; Stephen Zano; Reka Natarajan; Bryan Yamamoto; Ronald E Viola
Journal:  Mol Genet Metab       Date:  2014-07-12       Impact factor: 4.797

6.  Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Reza Falak; Mansour Heidari; Mahshid Sharzad; Elham Kalantari
Journal:  J Neural Transm (Vienna)       Date:  2016-09-24       Impact factor: 3.575

7.  Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Authors:  Fei Ye; Qiongqiong Zhan; Wenhuan Xiao; Weiwei Sha; Xiaobin Zhang
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

8.  MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.

Authors:  John H Anneken; Gary A Gudelsky
Journal:  Neuropharmacology       Date:  2012-07-25       Impact factor: 5.250

9.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

10.  Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.

Authors:  John H Anneken; Mariana Angoa-Perez; Girish C Sati; David Crich; Donald M Kuhn
Journal:  Neuropharmacology       Date:  2017-08-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.